Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ruby Yun-Ju Huang

Showing results (71-80 of 84) with videos related to

Pageof 9
Sort By:
Theranostics|January 4, 2021
Putting the BRK on breast cancer: From molecular target to therapeuticsHui Li Ang, Yi Yuan, Xianning Lai, et al.
Prenatal Diagnosis|June 30, 2021
A reasoned approach towards administering COVID-19 vaccines to pregnant womenAngsumita Pramanick, Abhiram Kanneganti, Jing Lin Jeslyn Wong, et al.
Cells|March 13, 2024
Secretome from Magnetically Stimulated Muscle Exhibits Anticancer Potency: Novel Preconditioning Methodology Highlighting HTRA1 ActionYee Kit Tai, Jan Nikolas Iversen, Karen Ka Wing Chan, et al.
Frontiers in Pharmacology|December 20, 2018
Thymoquinone Inhibits Bone Metastasis of Breast Cancer Cells Through Abrogation of the CXCR4 Signaling AxisMuthu K Shanmugam, Kwang Seok Ahn, Annie Hsu, et al.
Frontiers in Oncology|February 10, 2022
Modulated TRPC1 Expression Predicts Sensitivity of Breast Cancer to Doxorubicin and Magnetic Field Therapy: Segue Towards a Precision Medicine ApproachYee Kit Tai, Karen Ka Wing Chan, Charlene Hui Hua Fong, et al.
Frontiers in Oncology|May 6, 2022
Corrigendum: Modulated TRPC1 Expression Predicts Sensitivity of Breast Cancer to Doxorubicin and Magnetic Field Therapy: Segue Towards a Precision Medicine ApproachYee Kit Tai, Karen Ka Wing Chan, Charlene Hui Hua Fong, et al.
EMBO Molecular Medicine|May 14, 2013
Functional genomics identifies five distinct molecular subtypes with clinical relevance and pathways for growth control in epithelial ovarian cancerTuan Zea Tan, Qing Hao Miow, Ruby Yun-Ju Huang, et al.
Cell Death Discovery|September 28, 2021
Epigenetic derepression converts PPARγ into a druggable target in triple-negative and endocrine-resistant breast cancersSer Yue Loo, Nicholas L Syn, Angele Pei-Fern Koh, et al.
Cancer Research|September 26, 2019
RNA-Binding Protein <i>ZFP36L1</i> Suppresses Hypoxia and Cell-Cycle SignalingXin-Yi Loh, Qiao-Yang Sun, Ling-Wen Ding, et al.
Nature Communications|June 5, 2026
Targeting fibroblast TXNDC5 resolves tumor desmoplasia and PD-1 resistance in colorectal cancer with mesenchymal traitsKai-Lin Cheng, Chih-I Chen, Shu-Han Yu, et al.
Pageof 9

Showing results (71-80 of 84) with videos related to

Sort By:
Pageof 9
Theranostics|January 4, 2021
Putting the BRK on breast cancer: From molecular target to therapeuticsHui Li Ang, Yi Yuan, Xianning Lai, et al.
Prenatal Diagnosis|June 30, 2021
A reasoned approach towards administering COVID-19 vaccines to pregnant womenAngsumita Pramanick, Abhiram Kanneganti, Jing Lin Jeslyn Wong, et al.
Cells|March 13, 2024
Secretome from Magnetically Stimulated Muscle Exhibits Anticancer Potency: Novel Preconditioning Methodology Highlighting HTRA1 ActionYee Kit Tai, Jan Nikolas Iversen, Karen Ka Wing Chan, et al.
Frontiers in Pharmacology|December 20, 2018
Thymoquinone Inhibits Bone Metastasis of Breast Cancer Cells Through Abrogation of the CXCR4 Signaling AxisMuthu K Shanmugam, Kwang Seok Ahn, Annie Hsu, et al.
Frontiers in Oncology|February 10, 2022
Modulated TRPC1 Expression Predicts Sensitivity of Breast Cancer to Doxorubicin and Magnetic Field Therapy: Segue Towards a Precision Medicine ApproachYee Kit Tai, Karen Ka Wing Chan, Charlene Hui Hua Fong, et al.
Frontiers in Oncology|May 6, 2022
Corrigendum: Modulated TRPC1 Expression Predicts Sensitivity of Breast Cancer to Doxorubicin and Magnetic Field Therapy: Segue Towards a Precision Medicine ApproachYee Kit Tai, Karen Ka Wing Chan, Charlene Hui Hua Fong, et al.
EMBO Molecular Medicine|May 14, 2013
Functional genomics identifies five distinct molecular subtypes with clinical relevance and pathways for growth control in epithelial ovarian cancerTuan Zea Tan, Qing Hao Miow, Ruby Yun-Ju Huang, et al.
Cell Death Discovery|September 28, 2021
Epigenetic derepression converts PPARγ into a druggable target in triple-negative and endocrine-resistant breast cancersSer Yue Loo, Nicholas L Syn, Angele Pei-Fern Koh, et al.
Cancer Research|September 26, 2019
RNA-Binding Protein <i>ZFP36L1</i> Suppresses Hypoxia and Cell-Cycle SignalingXin-Yi Loh, Qiao-Yang Sun, Ling-Wen Ding, et al.
Nature Communications|June 5, 2026
Targeting fibroblast TXNDC5 resolves tumor desmoplasia and PD-1 resistance in colorectal cancer with mesenchymal traitsKai-Lin Cheng, Chih-I Chen, Shu-Han Yu, et al.
Pageof 9